-
1
-
-
0017762831
-
Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up
-
Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977;40:1365-85.
-
(1977)
Cancer
, vol.40
, pp. 1365-1385
-
-
Ridolfi, R.L.1
Rosen, P.P.2
Port, A.3
Kinne, D.4
Miké, V.5
-
2
-
-
0023917004
-
Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma
-
Rapin V, Contesso G, Mouriesse H, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988;61:2503-10.
-
(1988)
Cancer
, vol.61
, pp. 2503-2510
-
-
Rapin, V.1
Contesso, G.2
Mouriesse, H.3
-
3
-
-
84871357082
-
Carcinomas with medullary features
-
Lakhani SR, Ellis LO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. Lyon: IARC Press
-
Jacquemier J, Reis-Filho JS, Lakhani SR, Rakha E. Carcinomas with medullary features. In: Lakhani SR, Ellis LO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO classification of tumors of the breast. Lyon: IARC Press 2012;46-7.
-
(2012)
WHO classification of tumors of the breast
, pp. 46-47
-
-
Jacquemier, J.1
Reis-Filho, J.S.2
Lakhani, S.R.3
Rakha, E.4
-
4
-
-
33646390671
-
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
-
Bertucci F, Finetti P, Cervera N, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res 2006;66:4636-44.
-
(2006)
Cancer Res
, vol.66
, pp. 4636-4644
-
-
Bertucci, F.1
Finetti, P.2
Cervera, N.3
-
5
-
-
77955559694
-
Risk of mortality by histologic type of breast cancer in the United States
-
Li CI. Risk of mortality by histologic type of breast cancer in the United States. Horm Cancer 2010;1:156-65.
-
(2010)
Horm Cancer
, vol.1
, pp. 156-165
-
-
Li, C.I.1
-
6
-
-
21244462227
-
Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT)
-
Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 2005;62:1040-7.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.62
, pp. 1040-1047
-
-
Vu-Nishino, H.1
Tavassoli, F.A.2
Ahrens, W.A.3
Haffty, B.G.4
-
7
-
-
84868116683
-
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
-
Huober J1, Gelber S, Goldhirsch A, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012;23:2843-51.
-
(2012)
Ann Oncol
, vol.23
, pp. 2843-2851
-
-
Huober, J.1
Gelber, S.2
Goldhirsch, A.3
-
8
-
-
84876730988
-
Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified
-
Cao AY, He M, Huang L, Shao ZM, Di GH. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified. World J Surg Oncol 2013;11:91.
-
(2013)
World J Surg Oncol
, vol.11
, pp. 91
-
-
Cao, A.Y.1
He, M.2
Huang, L.3
Shao, Z.M.4
Di, G.H.5
-
9
-
-
80052486496
-
Medullary carcinoma of the breast: a population-based perspective
-
Martinez SR, Beal SH, Canter RJ, Chen SL, Khatri VP, Bold RJ. Medullary carcinoma of the breast: a population-based perspective. Med Oncol 2011;28:738-44.
-
(2011)
Med Oncol
, vol.28
, pp. 738-744
-
-
Martinez, S.R.1
Beal, S.H.2
Canter, R.J.3
Chen, S.L.4
Khatri, V.P.5
Bold, R.J.6
-
10
-
-
84892571466
-
Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma
-
Park I, Kim J, Kim M, et al. Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. J Breast Cancer 2013;16:417-25.
-
(2013)
J Breast Cancer
, vol.16
, pp. 417-425
-
-
Park, I.1
Kim, J.2
Kim, M.3
-
11
-
-
0021048541
-
The significance of lymph node involvement in patients with medullary carcinoma of the breast
-
Black CL, Morris DM, Goldman LI, McDonald JC. The significance of lymph node involvement in patients with medullary carcinoma of the breast. Surg Gynecol Obstet 1983;157:497-9.
-
(1983)
Surg Gynecol Obstet
, vol.157
, pp. 497-499
-
-
Black, C.L.1
Morris, D.M.2
Goldman, L.I.3
McDonald, J.C.4
-
12
-
-
0028784778
-
Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases
-
Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol 1995;60:89-94.
-
(1995)
J Surg Oncol
, vol.60
, pp. 89-94
-
-
Reinfuss, M.1
Stelmach, A.2
Mitus, J.3
Rys, J.4
Duda, K.5
-
13
-
-
33847147313
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
-
Wolff AC1, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-45.
-
(2007)
J Clin Oncol
, vol.25
, pp. 118-145
-
-
Wolff, A.C.1
Hammond, M.E.2
Schwartz, J.N.3
-
14
-
-
33645957984
-
Different patterns of inflammation and prognosis in invasive carcinoma of the breast
-
Lee AHS, Gillett CE, Ryder K, Fentiman IS, Miles DW, Millis RR. Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology 2006;48:692-701.
-
(2006)
Histopathology
, vol.48
, pp. 692-701
-
-
Lee, A.H.S.1
Gillett, C.E.2
Ryder, K.3
Fentiman, I.S.4
Miles, D.W.5
Millis, R.R.6
-
15
-
-
77953211478
-
Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach
-
Flucke U, Flucke MT, Hoy L, et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology 2010;56:852-59.
-
(2010)
Histopathology
, vol.56
, pp. 852-859
-
-
Flucke, U.1
Flucke, M.T.2
Hoy, L.3
-
16
-
-
77955242875
-
Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size
-
Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK. Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat 2010;42:30-6.
-
(2010)
Cancer Res Treat
, vol.42
, pp. 30-36
-
-
Lee, J.H.1
Kim, S.H.2
Suh, Y.J.3
Shim, B.Y.4
Kim, H.K.5
-
17
-
-
36549031706
-
Typical medullary carcinoma of the breast: a retrospective study about 33 cases
-
Khomsi F, Ben BachoucheW, Bouzaiene H, et al. Typical medullary carcinoma of the breast: a retrospective study about 33 cases. Gynecol Obstet Fertil 2007;35:1117-22.
-
(2007)
Gynecol Obstet Fertil
, vol.35
, pp. 1117-1122
-
-
Khomsi, F.1
Ben Bachouche, W.2
Bouzaiene, H.3
-
18
-
-
84896318363
-
A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women
-
Greer LT, Rosman M, Charles Mylander W, et al. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women. Breast J 2014;20:147-53.
-
(2014)
Breast J
, vol.20
, pp. 147-153
-
-
Greer, L.T.1
Rosman, M.2
Charles Mylander, W.3
-
19
-
-
84877113211
-
Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice
-
Yoshihara E, Smeets A, Laenen A, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast 2013;22:357-61.
-
(2013)
Breast
, vol.22
, pp. 357-361
-
-
Yoshihara, E.1
Smeets, A.2
Laenen, A.3
-
20
-
-
84864866573
-
Factors influencing axillary lymph node metastasis in invasive breast cancer
-
Li L, Chen LZ. Factors influencing axillary lymph node metastasis in invasive breast cancer. Asian Pac J Cancer Prev 2012;13:251-4.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 251-254
-
-
Li, L.1
Chen, L.Z.2
-
21
-
-
79952477226
-
Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma
-
Yenidunya S, Bayrak R, Haltas H. Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma. Diagn Pathol 2011;6:18.
-
(2011)
Diagn Pathol
, vol.6
, pp. 18
-
-
Yenidunya, S.1
Bayrak, R.2
Haltas, H.3
-
22
-
-
66949168510
-
The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast
-
Rakha EA, Aleskandarany M, El-Sayed ME, et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer 2009;45:1780-87.
-
(2009)
Eur J Cancer
, vol.45
, pp. 1780-1787
-
-
Rakha, E.A.1
Aleskandarany, M.2
El-Sayed, M.E.3
-
23
-
-
84865171628
-
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
-
Luporsi E, André F, Spyratos F, et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat 2012;132:895-915.
-
(2012)
Breast Cancer Res Treat
, vol.132
, pp. 895-915
-
-
Luporsi, E.1
André, F.2
Spyratos, F.3
-
24
-
-
48849096940
-
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients
-
Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients. Breast 2008;17:323-34.
-
(2008)
Breast
, vol.17
, pp. 323-334
-
-
Stuart-Harris, R.1
Caldas, C.2
Pinder, S.E.3
Pharoah, P.4
-
25
-
-
0031827485
-
MIB-1 labelling index is an independent prognostic marker in primary breast cancer
-
Jansen RL, Hupperets PS, Arends JW, et al. MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer 1998;78:460-5.
-
(1998)
Br J Cancer
, vol.78
, pp. 460-465
-
-
Jansen, R.L.1
Hupperets, P.S.2
Arends, J.W.3
-
26
-
-
77955203082
-
Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
-
Nishimura R1, Osako T, Okumura Y, Hayashi M, Toyozumi Y, Arima N. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Ther Med 2010;1:747-54.
-
(2010)
Exp Ther Med
, vol.1
, pp. 747-754
-
-
Nishimura, R.1
Osako, T.2
Okumura, Y.3
Hayashi, M.4
Toyozumi, Y.5
Arima, N.6
|